Literature DB >> 7671426

Coexisting lichen planus and subacute cutaneous lupus erythematosus.

S Grabbe1, G Kolde.   

Abstract

We report a patient who presented with annular erythematous skin lesions and generalized lichenoid papules. The clinical picture as well as histopathology, immunofluorescence and laboratory findings indicated coexistence of subacute cutaneous lupus erythematosus (SCLE) and extensive generalized lichen planus (LP). Clinically and histologically, SCLE-like lesions appeared to progress into LP-like lesions, supporting the concept of a common autoimmune pathophysiology in these disorders. Treatment with cyclosporin A (2.5 mg/kg body weight) resulted in a significant remission of the inflammatory skin lesions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7671426     DOI: 10.1111/j.1365-2230.1995.tb01315.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  5 in total

1.  [Cutaneous lupus erythematosus. Part 1: clinical manifestations and classification].

Authors:  A Kuhn; K Gensch; S Ständer; G Bonsmann
Journal:  Hautarzt       Date:  2006-03       Impact factor: 0.751

2.  Scle-lp overlap syndrome.

Authors:  C Shanmuga Sekar; Reena Rai; N Karthika; A Laila
Journal:  Indian J Dermatol       Date:  2011-03       Impact factor: 1.494

3.  Lupus erythematosus and lichen planus overlap syndrome:a case report with a rapid response to topical corticosteroid therapy.

Authors:  Gulsen Tukenmez Demirci; Ilknur Kıvanç Altunay; Sezgi Sarıkaya; Damlanur Sakiz
Journal:  Dermatol Reports       Date:  2011-11-25

Review 4.  The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review.

Authors:  Cecilia Beatrice Chighizola; Voon H Ong; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 10.817

Review 5.  Cutaneous lupus erythematosus: A review of the literature.

Authors:  Stephanie Clare Blake; Benjamin Silas Daniel
Journal:  Int J Womens Dermatol       Date:  2019-07-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.